JP2005536531A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005536531A5 JP2005536531A5 JP2004527368A JP2004527368A JP2005536531A5 JP 2005536531 A5 JP2005536531 A5 JP 2005536531A5 JP 2004527368 A JP2004527368 A JP 2004527368A JP 2004527368 A JP2004527368 A JP 2004527368A JP 2005536531 A5 JP2005536531 A5 JP 2005536531A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen atom
- hydroxy
- ophthalmic composition
- macrolide compound
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40206102P | 2002-08-09 | 2002-08-09 | |
| PCT/JP2003/010105 WO2004014373A1 (en) | 2002-08-09 | 2003-08-08 | Pharmaceutical compositions comprising fk506 derivatives and the ir use for the treatment of allergic diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010203075A Division JP2011012071A (ja) | 2002-08-09 | 2010-09-10 | アレルギー性疾患を処置する為のｆｋ５０６誘導体を含む医薬組成物及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005536531A JP2005536531A (ja) | 2005-12-02 |
| JP2005536531A5 true JP2005536531A5 (https=) | 2006-09-28 |
Family
ID=31715781
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004527368A Pending JP2005536531A (ja) | 2002-08-09 | 2003-08-08 | アレルギー性疾患を処置する為のｆｋ５０６誘導体を含む医薬組成物及びその使用 |
| JP2010203075A Pending JP2011012071A (ja) | 2002-08-09 | 2010-09-10 | アレルギー性疾患を処置する為のｆｋ５０６誘導体を含む医薬組成物及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010203075A Pending JP2011012071A (ja) | 2002-08-09 | 2010-09-10 | アレルギー性疾患を処置する為のｆｋ５０６誘導体を含む医薬組成物及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20050239813A1 (https=) |
| EP (1) | EP1536793A1 (https=) |
| JP (2) | JP2005536531A (https=) |
| KR (1) | KR20050054913A (https=) |
| CN (1) | CN1674896A (https=) |
| AU (1) | AU2003256068A1 (https=) |
| BR (1) | BR0313425A (https=) |
| CA (1) | CA2495103A1 (https=) |
| MX (1) | MXPA05001575A (https=) |
| WO (1) | WO2004014373A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003004098A1 (en) * | 2001-07-06 | 2003-01-16 | Sucampo Ag | Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| US7354574B2 (en) | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| US7083802B2 (en) * | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| CA2539324A1 (en) | 2003-09-18 | 2005-03-31 | Macusight, Inc. | Transscleral delivery |
| US7087237B2 (en) | 2003-09-19 | 2006-08-08 | Advanced Ocular Systems Limited | Ocular solutions |
| US7083803B2 (en) | 2003-09-19 | 2006-08-01 | Advanced Ocular Systems Limited | Ocular solutions |
| JP4974903B2 (ja) | 2005-02-09 | 2012-07-11 | 参天製薬株式会社 | 疾患または状態を処置するための液体処方物 |
| US8663639B2 (en) | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
| AU2006270041B2 (en) | 2005-07-18 | 2011-08-18 | Minu, Llc | Enhanced ocular neuroprotection/neurostimulation |
| CN1965825B (zh) * | 2005-11-17 | 2011-07-06 | 洪晶 | 一种治疗眼部免疫性疾病及抑制增殖、新生血管的眼表用药 |
| WO2007092620A2 (en) | 2006-02-09 | 2007-08-16 | Macusight, Inc. | Stable formulations, and methods of their preparation and use |
| PL2001466T3 (pl) | 2006-03-23 | 2016-06-30 | Santen Pharmaceutical Co Ltd | Rapamycyna w małej dawce do leczenia chorób związanych z przepuszczalnością naczyń |
| KR100891313B1 (ko) | 2007-08-17 | 2009-03-31 | (주) 제노텍 | 담체로 작용하는 흡착성 수지의 제공에 의한 트리사이클로화합물의 생산 및 추출 방법 |
| US8106111B2 (en) | 2009-05-15 | 2012-01-31 | Eastman Chemical Company | Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions |
| WO2014159679A1 (en) | 2013-03-12 | 2014-10-02 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Methods for using lubiprostone to absorb fluid from the subretinal space |
| KR101632042B1 (ko) * | 2014-06-30 | 2016-06-21 | 주식회사 인트론바이오테크놀로지 | Fk506 유도체를 함유하는 크립토코쿠스 속 곰팡이 및 칸디다 속 곰팡이에 의한 진균 감염을 치료하기 위한 약제학적 조성물 및 그의 용도 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2066915T3 (es) * | 1989-07-05 | 1995-03-16 | Fujisawa Pharmaceutical Co | Composicion liquida acuosa para uso externo. |
| CA2054983A1 (en) * | 1990-11-08 | 1992-05-09 | Sotoo Asakura | Suspendible composition and process for preparing the same |
| US5514686A (en) * | 1991-04-26 | 1996-05-07 | Fujisawa Pharmaceutical Co., Ltd. | Use of macrolide compounds for eye diseases |
| US7063857B1 (en) * | 1999-04-30 | 2006-06-20 | Sucampo Ag | Use of macrolide compounds for the treatment of dry eye |
| AU777915B2 (en) * | 1999-04-30 | 2004-11-04 | Sucampo Ag | Use of macrolide compounds for the treatment of dry eye |
| AR033151A1 (es) * | 2001-04-12 | 2003-12-03 | Sucampo Pharmaceuticals Inc | Agente para el tratamiento oftalmico topico de las enfermedades inflamatorias oculares |
| WO2003004098A1 (en) * | 2001-07-06 | 2003-01-16 | Sucampo Ag | Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| AU2002366028A1 (en) * | 2001-11-21 | 2003-06-10 | Sucampo Ag | Use of fk506 and analogues for treating allergic diseases |
-
2003
- 2003-08-08 MX MXPA05001575A patent/MXPA05001575A/es not_active Application Discontinuation
- 2003-08-08 AU AU2003256068A patent/AU2003256068A1/en not_active Abandoned
- 2003-08-08 CN CNA038190176A patent/CN1674896A/zh active Pending
- 2003-08-08 JP JP2004527368A patent/JP2005536531A/ja active Pending
- 2003-08-08 CA CA002495103A patent/CA2495103A1/en not_active Abandoned
- 2003-08-08 KR KR1020057002129A patent/KR20050054913A/ko not_active Withdrawn
- 2003-08-08 EP EP03784593A patent/EP1536793A1/en not_active Withdrawn
- 2003-08-08 US US10/523,842 patent/US20050239813A1/en not_active Abandoned
- 2003-08-08 BR BR0313425-3A patent/BR0313425A/pt not_active Application Discontinuation
- 2003-08-08 WO PCT/JP2003/010105 patent/WO2004014373A1/en not_active Ceased
-
2010
- 2010-09-10 JP JP2010203075A patent/JP2011012071A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005536531A5 (https=) | ||
| JP2005502621A5 (https=) | ||
| JP2005539088A5 (https=) | ||
| JP2007538024A5 (https=) | ||
| JP2004530691A5 (https=) | ||
| JP2005511699A5 (https=) | ||
| EP1857457A3 (en) | Benzimidazole derivative and its use as AII receptor antagonist | |
| JP2003509349A5 (https=) | ||
| JP2002535323A5 (https=) | ||
| JP2008510828A5 (https=) | ||
| JP2012510502A5 (https=) | ||
| JP2005527593A5 (https=) | ||
| JP2015025011A5 (https=) | ||
| JP2020507589A5 (https=) | ||
| JP2008526999A5 (https=) | ||
| JP2014514290A5 (https=) | ||
| JP2019513745A5 (https=) | ||
| JP2004529928A5 (https=) | ||
| JP2013515037A5 (https=) | ||
| JPWO2023195529A5 (https=) | ||
| JP2016500653A5 (https=) | ||
| JP2010514733A5 (https=) | ||
| AR065297A1 (es) | Formulaciones biodisponibles de compuestos heterociclicos | |
| JP2005526773A5 (https=) | ||
| RU2009128968A (ru) | Производные изосорбидмононитрата для лечения повышенной внутриглазной гипертензии |